Additionally, low CASZ1 expression exhibits a significant association with increasing patient age, high-risk classification of pediatric tumor group, loss of heterozygosity on chromosome 1p (1p LOH), MYCN amplification, and reduced survival probability. The gene discussed is CASZ1; the disease is neoplasm.